WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareHealthcare Plans
Best Healthcare Plan Stocks to Buy Now (2024)
Top healthcare plan stocks in 2024 ranked by overall Zen Score. See the best healthcare plan stocks to buy now, according to analyst forecasts for the healthcare plans industry.

Industry: Healthcare Plans
Ticker
Company
Forecast Score
Market Cap
Price
Price Target
Upside/Downside
Top Analysts Upside/Downside
Consensus
Top Analysts Consensus
Analysts
Top Analysts
Fore. Revenue Growth
Fore. Earnings Growth
Forecast ROE
Forecast ROA
CNC
CENTENE CORP
$40.19B$75.15$89.0018.43%Strong Buy6-0.62%44.17%N/AN/A
CVS
CVS HEALTH CORP
$87.78B$69.75$88.6027.03%Strong Buy105.05%37.17%N/AN/A
HUM
HUMANA INC
$39.61B$328.33$430.2731.05%Buy154.48%40.51%N/AN/A
CI
CIGNA GROUP
$103.02B$352.39$375.546.57%Strong Buy139.55%41.67%N/AN/A
MOH
MOLINA HEALTHCARE INC
$21.46B$367.52$417.7113.66%Buy712.57%21.44%N/AN/A
UNH
UNITEDHEALTH GROUP INC
$462.01B$501.13$567.6413.27%Strong Buy147.12%13.13%41.91%13.59%
ELV
ELEVANCE HEALTH INC
$123.51B$531.42$592.1311.42%Strong Buy84.06%22.14%N/AN/A
OSCR
OSCAR HEALTH INC
$3.68B$16.01$16.251.50%Strong Buy426.35%N/AN/AN/A
ALHC
ALIGNMENT HEALTHCARE INC
$982.68M$5.20$8.5464.15%Hold723.38%N/AN/AN/A
CLOV
CLOVER HEALTH INVESTMENTS CORP
$315.01M$0.64N/AN/AN/AN/A-13.07%N/AN/AN/A
NEUE
NEUEHEALTH INC
$46.87M$5.82$8.0037.46%Hold124.93%N/A-6.63%6.84%
MRAI
MARPAI INC
$24.00M$2.33$6.00157.51%Strong Buy1N/AN/AN/AN/A

Healthcare Plan Stocks FAQ

What are the best healthcare plan stocks to buy right now in Apr 2024?

According to Zen Score, the 3 best healthcare plan stocks to buy right now are:

1. Centene (NYSE:CNC)


Centene (NYSE:CNC) is the top healthcare plan stock with a Zen Score of 62, which is 22 points higher than the healthcare plan industry average of 40. It passed 20 out of 33 due diligence checks and has strong fundamentals. Centene has seen its stock return 12.53% over the past year, overperforming other healthcare plan stocks by 7 percentage points.

Centene has an average 1 year price target of $89.00, an upside of 18.43% from Centene's current stock price of $75.15.

Centene stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 6 analysts covering Centene, 66.67% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Cvs Health (NYSE:CVS)


Cvs Health (NYSE:CVS) is the second best healthcare plan stock with a Zen Score of 52, which is 12 points higher than the healthcare plan industry average of 40. It passed 18 out of 38 due diligence checks and has strong fundamentals. Cvs Health has seen its stock lose -6.01% over the past year, underperforming other healthcare plan stocks by -11 percentage points.

Cvs Health has an average 1 year price target of $88.60, an upside of 27.03% from Cvs Health's current stock price of $69.75.

Cvs Health stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 10 analysts covering Cvs Health, 50% have issued a Strong Buy rating, 30% have issued a Buy, 20% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Humana (NYSE:HUM)


Humana (NYSE:HUM) is the third best healthcare plan stock with a Zen Score of 51, which is 11 points higher than the healthcare plan industry average of 40. It passed 18 out of 38 due diligence checks and has strong fundamentals. Humana has seen its stock lose -33.39% over the past year, underperforming other healthcare plan stocks by -39 percentage points.

Humana has an average 1 year price target of $430.27, an upside of 31.05% from Humana's current stock price of $328.33.

Humana stock has a consensus Buy recommendation according to Wall Street analysts. Of the 15 analysts covering Humana, 40% have issued a Strong Buy rating, 13.33% have issued a Buy, 46.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare plan stocks with highest dividends?

Out of 5 healthcare plan stocks that have issued dividends in the past year, the 3 healthcare plan stocks with the highest dividend yields are:

1. Cvs Health (NYSE:CVS)


Cvs Health (NYSE:CVS) has an annual dividend yield of 3.64%, which is 2 percentage points higher than the healthcare plan industry average of 1.76%. Cvs Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cvs Health's dividend has shown consistent growth over the last 10 years.

Cvs Health's dividend payout ratio of 38.2% indicates that its dividend yield is sustainable for the long-term.

2. Unitedhealth Group (NYSE:UNH)


Unitedhealth Group (NYSE:UNH) has an annual dividend yield of 1.5%, which is the same as the healthcare plan industry average of 1.76%. Unitedhealth Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Unitedhealth Group's dividend has shown consistent growth over the last 10 years.

Unitedhealth Group's dividend payout ratio of 30.2% indicates that its dividend yield is sustainable for the long-term.

3. Cigna Group (NYSE:CI)


Cigna Group (NYSE:CI) has an annual dividend yield of 1.44%, which is the same as the healthcare plan industry average of 1.76%. Cigna Group's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Cigna Group's dividend has shown consistent growth over the last 10 years.

Cigna Group's dividend payout ratio of 28% indicates that its dividend yield is sustainable for the long-term.

Why are healthcare plan stocks up?

Healthcare plan stocks were up 1.29% in the last day, and up 5.24% over the last week. Unitedhealth Group was the among the top gainers in the healthcare plans industry, gaining 1.61% yesterday.

UnitedHealth shares are trading higher after Deutsche Bank raised its price target on the stock from $545 to $562. The stock has continued to gain following Tuesday's Q1 earnings report.

What are the most undervalued healthcare plan stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued healthcare plan stocks right now are:

1. Humana (NYSE:HUM)


Humana (NYSE:HUM) is the most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Humana has a valuation score of 71, which is 40 points higher than the healthcare plan industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Humana's stock has dropped -33.39% in the past year. It has underperformed other stocks in the healthcare plan industry by -39 percentage points.

2. Centene (NYSE:CNC)


Centene (NYSE:CNC) is the second most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Centene has a valuation score of 71, which is 40 points higher than the healthcare plan industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Centene's stock has gained 12.53% in the past year. It has overperformed other stocks in the healthcare plan industry by 7 percentage points.

3. Cvs Health (NYSE:CVS)


Cvs Health (NYSE:CVS) is the third most undervalued healthcare plan stock based on WallStreetZen's Valuation Score. Cvs Health has a valuation score of 71, which is 40 points higher than the healthcare plan industry average of 31. It passed 5 out of 7 valuation due diligence checks.

Cvs Health's stock has dropped -6.01% in the past year. It has underperformed other stocks in the healthcare plan industry by -11 percentage points.

Are healthcare plan stocks a good buy now?

63.64% of healthcare plan stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare plan stocks to rise by 15.28% over the next year.

What is the average p/e ratio of the healthcare plans industry?

The average P/E ratio of the healthcare plans industry is 18.91x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.